Coronavirus (CoV) transcription implies a discontinuous mechanism by which the 5′-terminal leader sequence is fused to the 5′ end of the mRNA coding sequence (body). Transcription-regulating sequences (TRSs) preceding each gene include a conserved core, also found at the 3′-end of the leader, and variable 5′ and 3′ flanking sequences. Base pairing between the leader TRS (TRS-L) and the complement of the body TRS (cTRS-B) in the nascent RNA is a main determinant factor during CoV transcription. In transmissible gastroenteritis CoV, a good correlation has been observed between subgenomic mRNA levels (sgmRNA) and the free energy of TRS-L and cTRS-B duplex formation, with the only exception of sgmRNA N, the most abundant during viral infection in spite of its minimum free energy. Consequently, we postulated the presence of additional factors that regulate transcription of sgmRNA N. In fact, we have demonstrated the presence of a transcription enhancer preceding the coding sequences of N gene. These sequences have an enhancer activity not previously described within the *Nidovirales* order. SARS-CoV attenuated phenotypes were engineered in which the structural E gene (delta E), the group specific genes 6, 7a, 7b, 8a, 8b and 9b (delta 6--9), or E plus the group specific genes (delta E, 6--9) were deleted using an infectious cDNA clone. Viral particles with a morphology similar to that of the parental virus were observed in monkey cells in all cases. The virulence and induction of protection by the mutant viruses have been evaluated in two animal models: hamsters and transgenic mice expressing the SARS-CoV receptor hACE-2. The delta E virus was attenuated in hamsters and transgenic mice, and provided protection against homologous and heterologous SARS-CoV strains in both animal models. The data indicates that E gene is a virulence factor, and that viruses in which this gene has been deleted are promising vaccine candidates.
